Here are three things to know:
1. The company’s Physio product is a physiologic bone tissue allograft comprised of processed cortical bone tissue using Stability’s proprietary process.
2. Stability’s H100 Demineralized Bone Matrix is an allograft bone void filler offering a scaffold for mesenchymal cells, osteoprogenitor cells and osteboblasts. It has a variety of orthopedic and spine applications.
3. Brian Martin is the CEO and co-founder of Stability Biologics. He has more than 20 years of business experience.
More articles on biologics:
Researchers create biocompatible hydrogel 10 times more adhesive than fibrin
SurGenTec & Aziyo Biologics partner to launch MIS bone graft delivery system: 5 insights
ORTHOReBIRTH USA partners with Adventist Health System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
